Sponsored Links
| Valeant And GlaxoSmithKline Announce U.S. FDA Approval Of Potiga(TM) (Ezogabine) |
 |
 |
 |
| Pharmacy - Pharma Industry - Biotech Industry | |||
|
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) and GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga(TM) (ezogabine) Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older. "We are so pleased to reach such an important milestone with the U... Read more: Pharma Industry / Biotech Industry News From Medical News Today
|